Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Daniel Addison, MD, and Danielle Shafer, DO, discuss the latest updates in the prevention and treatment of cardiovascular disease in patients with chronic lymphocytic leukemia.
Nicolas Palaskas, MD, and Susan Dent, MD, provide a review of the latest developments in the diagnosis and management of diverse immune checkpoint-related adverse cardiovascular events, including myocarditis.
Katelyn Atkins, MD, PhD discusses cardiovascular diseases associated with radiation therapy and risk mitigation approaches. Moderated by Sarah Waliany, MD, MS.
Commentary by Dr. Abdullah Al-Abcha and Dr. Dharam J. Kumbhani
Commentary by Dr. Megha Prasad and Dr. Akiko Maehara
Neeja Patel MD, and Unjali Gujral, MPH,PhD discuss the epidemiology of metabolic syndrome relating to cardiovascular disease, differences within various ethnic groups, the effect of acculturation, and approaches to address large population health in the future.
Audio Summary of the February Issue with Introduction by Dr. Bonnie Ky.
Commentary by Dr. Nazish Sayed
Commentary by Dr. Richard Von Itter
Commentary by Dr. Vivek Narayan
Commentary by Dr. Laura De Michieli
Commentary by Dr. Tzu-Fei Wang
Commentary by Dr. Bobby Yeh and Dr. Aarti Asnani
Commentary by Dr. Candice Silversides, Dr. Thomas Pearson, and Dr. Charlotte Pratt
Commentary by Dr. Mirza Umair Khalid and Dr. Bashir Alaour
Commentary by Dr. Mirza Umair Khalid and Dr. Christopher R. Ellis